NHS Dudley Health Economy Medicines Formulary
Home > 2 Cardiovascular system > 2.9 Antiplatelet drugs > Acute coronary syndrome - prasugrel - NICE TAG TA182

Acute coronary syndrome - prasugrel - NICE TAG TA182

1.1 Prasugrel in combination with aspirin is recommended as an option for preventing atherothrombotic events in people with acute coronary syndromes having percutaneous coronary intervention, only when:

  • immediate primary percutaneous coronary intervention for ST-segment-elevation myocardial infarction is necessary or

  • stent thrombosis has occurred during clopidogrel treatment or

  • the patient has diabetes mellitus.

1.2 People currently receiving prasugrel for treatment of acute coronary syndromes whose circumstances do not meet the criteria in 1.1 should have the option to continue therapy until they and their clinicians consider it appropriate to stop.

https://www.nice.org.uk/guidance/TA182

Site by Devopa
© Copyright 2020 NHS. All rights reserved.